Table 1.
Baseline characteristics from a cluster-randomized clinical trial in Ethiopia comparing intensive latrine promotion with no latrine intervention*
| Characteristic | Latrine promotion | Control | ||
|---|---|---|---|---|
| No. | Proportion (95% CI) | No. | Proportion (95% CI) | |
| Total population ≥ 1 year of age | 16,370 | 18,682 | ||
| Female | 8,253 | 50.4% (49.6–51.2) | 9,278 | 49.7% (49.0–50.4) |
| Received oral azithromycin | 13,943 | 85.2% (82.4–87.9) | 17,190 | 92.0% (89.9–94.2) |
| Ages 1–5 years | 2,578 | 2,929 | ||
| Female | 1,288 | 50.0% (48.2–51.7) | 1,461 | 49.9% (47.8–52.0) |
| Received oral azithromycin | 2,160 | 83.8% (80.4–87.2) | 2,754 | 94.0% (91.6–96.4) |
| Ages 6–10 years | 3,074 | 3,686 | ||
| Female | 1,589 | 51.7% (49.5–53.9) | 1,794 | 48.7% (47.1–50.2) |
| Received oral azithromycin | 2,798 | 91.0% (88.2–93.9) | 3.521 | 95.5% (93.5–97.6) |
| Ages 11–20 years | 4,111 | 4,577 | ||
| Female | 2,101 | 51.1% (49.7–52.5) | 2,281 | 49.8% (48.3–51.3) |
| Received oral azithromycin | 3,449 | 83.9% (81.6–86.2) | 4,142 | 90.5% (88.3–92.6) |
| Ages > 20 years | 6,607 | 7,490 | ||
| Female | 3,275 | 49.6% (48.3–50.8) | 3,742 | 50.0% (48.6–51.3) |
| Received oral azithromycin | 5,536 | 83.8% (79.1–88.4) | 6,773 | 90.4% (87.9–92.9) |
*
No. = number of persons; CI = confidence interval.